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Edited by Pascale CossartAbstract Mono ADP-ribosyltransferases (ARTs) are a family
of enzymes related to bacterial toxins that possess adenosine
diphosphate ribosyltransferase activity. We have assessed that
A549 constitutively expressed ART1 on the cell surface and
shown that lipotheicoic acid (LTA) and ﬂagellin, but not lipo-
polysaccharide (LPS), peptidoglycan (PG) and poly (I:C), up-
regulate ART1 in a time and dose dependent manner. These
agonists did not alter the expression of ART3 and ART5 genes.
Indeed, LTA and ﬂagellin stimulation increased the level of
ART1 protein and transcript while ART4 gene was activated
after stimulation of cells with LPS, LTA, PAM and PG via
TLR2 and TLR4 receptors. These results show that human
ARTs possess a diﬀerential capacity to respond to bacteria cell
wall components and might play a crucial role in innate immune
response in airways.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Mono ADP-ribosylation is a covalent chemical modiﬁcation
process catalyzed by ADP-ribosyltransferases (ARTs), which
attach a single moiety of ADP-ribose of NAD to speciﬁc ami-
no-acid residues of acceptor proteins [1]. This reaction is also a
widely used mechanism of bacterial pathogenesis, indeed
pathogens, like Bordetella pertussis, Vibrio cholerae, Esche-
richia coli, and Clostridium botulinum, synthesize ADP-ribo-
syltransferases as exotoxins able to interrupt cellular
metabolic and regulatory pathways [2]. The family of known
mammalian ARTs related in structure and function to pro-
karyotic toxins consists of ﬁve members (ART1-5). Arginine
is the amino-acid target for ART1, ART2, and ART5, whileAbbreviations: ART, mono ADP-ribosyltransferase; LPS, lipopolysac-
charide; LTA, lipoteichoic acid; PAM, Pam3-CSK4; PG, peptidogly-
can; qRT-PCR, quantitative reverse transcription-polymerase chain
reaction; PAMP, pathogen associated molecular pattern; TLR, Toll-
like receptor
*Corresponding author. Address: Centro Ricerche, Novartis Vaccines,
Via Fiorentina 1, 53100 Siena, Italy. Fax: +39 0577 243564.
E-mail address: enrico_balducci@chiron.com (E. Balducci).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.07.061the amino-acid acceptor(s) for ART3 and ART4 have not been
characterized yet. Since ART2 is not expressed in humans due
to three premature stop codons [3] the only arginine-modifying
ARTs expressed in humans are ART1 and ART5. It has been
shown that ART1, which is constitutively expressed on the sur-
face of cells lining the airway lumen [4], modiﬁes the Arg-14 of
a-defensin-1 (HNP-1), an antimicrobial peptide released by
neutrophils, altering its biological activities [5]. Remarkably
ADP-ribosylated-a-defensin-1 was puriﬁed from bronchoal-
veloar lavage (BAL) of smokers, showing that this modiﬁca-
tion occurs in vivo. Human Toll-like receptors (TLRs) act at
the host-pathogen interface and represent the earliest surveil-
lance system for primary infection by pathogens. So far 11
TLRs have been identiﬁed and shown to recognize a variety
of pathogen associated molecular patterns (PAMPs).
Although, TLRs are diﬀerentially expressed in a wide range
of immune cells, several studies have provided evidence that
also lung epithelial cells, which represent one of the ﬁrst lines
of defense against microbial attack in airways, constitutively
express TLRs playing a pivotal role in innate immunity.
Therefore, given that there are a number of potential TLR
agonists in the lung, we decided to evaluate whether airway
epithelial cells express transferase activity and to use these cells
as experimental model to determine how PAMPs aﬀect ART
activity and/or expression. Here, we report that ART1 is con-
stitutively expressed on the surface of A549 cells, which retain
features of type II alveolar epithelial cells [6]. We also estab-
lished that stimulation of A549 cells with TLR agonists led
to up-regulation of ART1 and expression of ART4 mRNA
indicating a potentially important function for ADP-ribosyla-
tion in airway epithelial cells.2. Materials and methods
2.1. Materials
[Adenine-U-14C] NAD (274 mCi/mmol) were purchased from Amer-
sham; Dowex AG 1-X2 from Bio-Rad; Dulbecco’s modiﬁed Eagle’s
minimum essential medium (DMEM) was from Gibco BRL. LPS from
E. coli serotype R515, ﬂagellin puriﬁed from Salmonella typhimurium
strain 14028 and Pam3CSK4 were from Alexis, stealth RNAi duplexes
against ART1 and all the reagents for transfection are from Invitro-
gen, the anti TLR4 mAb HTA125 and the anti TLR2 mAb T2.5 are
from eBioscience while PG and LTA from Staphylococcus aureus were
from Sigma-Aldrich as the other reagents used in this study. The A549
cell line was purchased from ATCC while Chinese hamster ﬁbroblast
V79 cells transfected with pTet-ON-ART1 cDNA were a kind gift of
Dr. J. Mac Dermot [7].blished by Elsevier B.V. All rights reserved.
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Cells cultured in DMEM containing HEPES 25 mM were trypsini-
zed at the exponential growth phase and collected by centrifugation
at 900 · g for 5 min, washed three times in PBS and lysed in hypotonic
lysis buﬀer (10 mM Tris–HCl, pH 8, and 1 mM EDTA) containing the
protease cocktail of Boehringer Mannheim. To purify membranes, cell
lysates were disrupted in dry ice for 10 min followed by centrifugation
at 100000 · g at 4 C for 1 h. The supernatant was collected and the
membrane fraction obtained suspended in the same lysis buﬀer and
sonicated three times before assaying for transferase activity. V79 cells
stably transfected with ART1 were cultured in selective DMEM med-
ium containing 200 lg/ml geneticin and 100 lg/ml hygromicin. Cell-
surface expression of ART1 was induced incubating cells for 48 h in
the presence of 2 lg/ml of deoxycycline.
2.3. ADP-ribosyltransferase enzymatic assay
Intact A549 cells and membranes were assayed for ADP-ribosyl-
transferase using a standard assay [8], carried out in 0.3 ml containing
50 mM potassium phosphate, pH 7.5, 20 mM agmatine and 0.1 mM
[adenine-U-14C] NAD (0.05 lCi). After incubation at 30 C, duplicate
samples (100 ll) were applied to 1 ml columns of Dowex AG 1-X2.
[Adenine-14C] ADP-ribosylagmatine was eluted for radioassay with
5 ml of H2O and the radioactivity counted in a Packard mod counter.
2.4. Immunoprecipitation and immunoblotting assays
Proteins resolved by SDS–PAGE (10% NuPAGE gel system using
MES as running buﬀer) were electrophoretically transferred to nitro-
cellulose using a Bio-Rad apparatus. Membranes were probed with
speciﬁc antibodies as speciﬁed in ﬁgure legends; bound antibodies were
detected using an ECL immunoblotting detection system (Bio-Rad)
according to the manufacturer’s instructions. Molecular masses were
estimated from calibration standard included in each gel. a-ART1
antibodies were customized by Primm srl using two ART1 speciﬁc pep-
tides, NH2-SQWQERQARWPEWSL-COOH and NH2-
CHLDNSAMGQSPLSA-COOH, coupled with OVA and aﬃnity
puriﬁed. Immunoprecipitation was performed using the Reversible
Immunoprecipitation System from Upstate following vendor’ instruc-
tions.
2.5. ART1 silencing
To silence ART1 we used three speciﬁc RNAi duplexes (shown be-
low), selected by Invitrogen within the open reading frame of human
ART1 gene.
(1) 5 0-GCCUGCUAUGAUGUCUCUGCUUCUU-3 0;
(2) 5 0-GCAGUUUGGUGAGGACACCUUCUUC-3 0;
(3) 5 0-CCAUCUGGAUAAUUCAGCCAUGGGU-3 0.
Scrambled RNAi duplex from Invitrogen was used as negative con-
trol. Among the three duplexes used, only RNAi duplex 3 consistently
inhibited ART activity. The delivery of RNAi duplexes (30 nM) was
performed using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. The eﬃciency of transfection was assessed
using the ﬂuorescent dye Block-it (Invitrogen). Brieﬂy, A549 cells pla-
ted onto 100 mm dishes in complete DMEM w/o antibiotics grown to
30–50% conﬂuency were transfected with RNAi duplexes. After 48 h
incubation membranes were puriﬁed from cells and assayed for trans-
ferase activity.Table 1
ART and Actin gene-speciﬁc primers
Gene Forward 5 0–3 0 Reve
ART1 CAGATGCCTGCTATGATGTC TCAA
AGCCAATGGCAGGAGCGTCA TCAA
ART3 GCAACCATGATTCTAGTGGAC GATA
ART4 TCT TTTGATGATCAGTACCAA GAGA
ART5 ATCCTGCCCCTGAGCCTGGTT GACA
ATCCTGCCCCTGAGCCTGGTT CGCA
b-Actin ATGGATGATGATATCGCCGCG CTAG
ATCTGGCACCACACCTTCTACAATGAGCTGCG CGTC2.6. RNA puriﬁcation and semiquantitative RT-PCR
Total RNA was puriﬁed from A549 (3 · 106 cells) using the RNA-
easy mini kit (Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions. For RT-PCR, 1 lg of total RNA was reverse
transcribed in cDNA at 55 C for 2 h with Superscript III and 50 pmol
each of ART1, ART3, ART4, ART5 and b-actin gene-speciﬁc primers
(Table 1) using the One-step RT-PCR system from Invitrogen. The
integrity of RNA and cDNA synthesis was veriﬁed by PCR measuring
the amounts of the housekeeping gene b-actin. The touch-down ampli-
ﬁcation was performed directly after retro transcription with an initial
denaturation step at 95 C for 2 min, the initial annealing temperature
was 70 C for 1 min followed by 15 cycles, in which temperature de-
creased 1 C per cycle. At annealing temperature of 55 C, 25 cycles
were repeated for 90 s followed by an extension phase of 90 s at
72 C. A ﬁnal extension phase at 72 C for 15 min was also performed.
PCR products were resolved on 1% Tris–acetate–EDTA (TAE)-aga-
rose gels containing 0.5 lg/ml ethidium bromide. The forward and re-
verse primers all intron-spanning are shown in Table 1.
2.7. Real-time quantitative RT-PCR
The cDNA was synthesized from total RNA puriﬁed as previously
described in 2.6 using the ThermoScript RT-PCR system from Invitro-
gen and used as template in real time PCR. The PCR mixture in a ﬁnal
volume of 25 ll was prepared using the iQSYBR Green supermix
from Bio-Rad containing the reference dye and 2 ll of cDNA tem-
plate. The primer pairs for ART1 gene and actin housekeeping gene
as a control reference were added at a ﬁnal concentration of
200 nM/primer. Samples were run in triplicate in a Chromo-4machine
(Bio-Rad) using appropriate 96-well plate. Sample mixtures underwent
to the following reaction protocol: initial denaturation at 95 C for
3 min, followed by 49 cycles of 95 C for 15 s and 57 C for 30 s and
elongation at 72 C for 30 s. Samples without cDNA and with water
instead of template were used as controls and blanks, respectively.
The primers used for ART1 and the housekeeping gene actin were:
ART1F 5 0-TTGCTGCTGCTGCTCTG-3 0.
ART1R 5 0-AGGAATTCTTGGTTACACTGAAG-3 0.
ACTF 5 0-GCGAGAAGATGACCCAGATC-30.
ACTR 5 0-GGATAGCACAGCCTGGATAG-3 0.
The PCR ampliﬁed product lengths are 150 and 77 bp for ART1 and
actin, respectively. Eﬃciency and speciﬁcity of the reaction calculated
using a serial dilution of cDNA was maximal for the pairs of primers
used. Following PCR, the melting curve for each product was deter-
mined and the correct size calculated by agarose gel analysis. Statistical
analysis for each product was performed using a Bio-Rad software
based on the method as described in [9].
2.8. TLR4 and TLR2 neutralization by speciﬁc monoclonal antibodies
A549 cells cultivated in DMEM complete medium in a 6-well culture
plate were pre-incubated with 20 lg/ml of anti-TLR4 (HTA125) and
50 lg/ml anti-TLR2 (T2.5) as suggested by the vendor. After 1 h we
added the stimuli at the concentrations described in ﬁgure legends.
2.9. Protein assay
Protein content of the membrane preparation and cell lysates was
determined using the Bradford assay (Bio-Rad) with BSA (2 mg/ml,
Pierce Chemical Co.) as standard.rse 5 0–3 0 Product size (bp)
AGGAGGCCTGGACCAT 981
AGGAGGCCTGGACCAT 735
AACAATGCATCAAACTACAGAGC 1083
GAGATGCAATAGCTATA 722
CACAGCCACGTCTCTTC 741
GTTAAAGTGGCTGCAGG 703
AAGCATTTGCGGTGGACGATGGAGGGGCC 1003
ATACTCCTGCTTGCTGATCCACATC 838
Fig. 2. Expression of ART1 in A549 cells. (a) Total RNA extracted
from A549 (1 lg) was reverse transcribed following the procedure
explained in Section 2.6. PCR was carried out with ART1 full-length
(lane 3) and nested (lane 4) primers or with ART5 full length (lane 3)
and nested (lane 4) primers. As positive control for ART1 and ART5
we used 0.5 lg of skeletal muscle and testis RNA, respectively,
ampliﬁed with full-length (lane 1) and nested (lane 2) primers. In lane
5, PCR was performed with ART1 and ART5 full-length primers
without previous RT. b-Actin was ampliﬁed as positive control for
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3.1. A549 cells express an enzymatically active ART1 on the cell
surface
As shown in Fig. 1, A549 intact cells express an arginine-spe-
ciﬁc ART activity. In agreement with the concept that ARTs
are ecto-enzymes, this ART-activity is associated with mem-
brane fraction. Since ART1 and ART5 are the only arginine-
speciﬁc enzymes expressed in humans [10,11] we looked for
their expression in A549 cells. As shown in Fig. 2a, ART1,
but not ART5, mRNA was detected by RT-PCR with full-
length (lane 3) and nested primers (lane 4). The ampliﬁed
PCR product was shown to be ART1 by sequencing. Expres-
sion of ART1 in A549 cells was conﬁrmed by western blot
analysis of immunoprecipitates of puriﬁed membranes probed
with a-ART1 polyclonal antibody (Fig. 2b) and by speciﬁc
ART1 silencing (Fig. 2c).
3.2. LTA and ﬂagellin induce up-regulation of ART1
Lung epithelium represents one of the ﬁrst barriers against
pathogens and can be exposed to a variety of PAMPs. Since
ARTs are present at the apical surface of airway epithelial cells
[4] we decided to investigate if agonists of the TLR4 and TLR2
that are functionally expressed in A549 cells [12,13] aﬀect ART
activity and expression. Therefore, we stimulated A549 with
LPS (TLR4 agonist), LTA (TLR2 agonist) or PG whose target
are NOD proteins [14] and evaluated the membrane-associated
ART-activity. As shown in Fig. 3a, arginine-speciﬁc ART-
activity was enhanced 1.4- and 3.7-fold, 12 and 24 h after stim-
ulation with LTA, while LPS and PG had no eﬀect. When we
performed a dose-response experiment, we observed that LTA
induced a 1.75-fold increase over the basal level already at
0.1 lg/ml, while 10 lg/ml was as eﬀective as 1 lg/ml inducing
the transferase activity 3.6- and 3.4-fold, respectively. On the
other hand the other PAMPs used, LPS and PG, failed to have
similar patterns even at 1 or 10 lg/ml (Fig. 3b). Since it has
been shown that A549 express also TLR5 [15] and TLR3
[16] we decided to test ﬂagellin (TLR5 agonist) and poly(I:C)
(TLR3 agonist) on ART-activity of A549 cells. Flagellin at
10 lg/ml increased transferase activity 2.7-fold over the basalFig. 1. A549 cells express a cell-surface arginine-speciﬁc ART. A549
cells from three 75 cm2 ﬂasks containing approximately 2 · 106 cells
each were trypsinized and resuspended in PBS. Half of the cells were
kept intact, part was lysed and membranes puriﬁed as described in
Section 2.2. The arginine-speciﬁc ART-activity was assayed using the
agmatine-based assay following the conditions described in Section
2.2. The values presented are the means ± S.D. of three diﬀerent
preparations.
A549 (lane 6). PCR products were 981 and 735 bp for ART1, 741 and
703 for ART5, 1003 and 838 for b-actin. Positions of molecular mass
markers (M) are on the left. (b) Immuno-precipitates from membranes
puriﬁed from A549 cells (20 lg/lane) were analyzed by immunoblot
with a-ART1 rabbit polyclonal antibody. Positive controls were
immuno-precipitates from membranes puriﬁed from ART1-transfec-
ted V79 cells incubated with doxycycline (Dox) to induce ART1
expression treated or not with 1 (U/ml) of PI-PLC for 1 h at 37 C to
release ART1. Immuno-precipitates were also obtained from the
supernatant of ART1-transfected V79 cells treated with PI-PLC.
Negative controls were immunoprecipitates obtained from membranes
and supernatant of V79 cells untreated with Dox. One representative
experiment out of three is shown. (c) Untransfected A549 cells
(control) or cells transfected with 30 nM of scrambled SiRNA (control
SiRNA) or SiRNA targeting ART1 (ART1 SiRNA) were analyzed for
transferase activity. After 48 h from transfection, membranes were
puriﬁed and used to measure the arginine-speciﬁc transferase activity.
Data show one representative experiment out of two.level after 24 h of stimulation, while poly(I:C) had no eﬀect
(Fig. 4a). To check if the up-regulation of ART-activity is
due to an increase in ART1 protein expression, membranes
used for the enzymatic assay were immuno-precipitated as de-
scribed in methods, resolved by electrophoresis, and blotted.
Fig. 3. The arginine-speciﬁc ART activity is increased by LTA. A549
were left untreated (none), stimulated with LPS (0.1 lg/ml), LTA
(1 lg/ml) or PG (1 lg/ml) for 6, 12 and 24 h (a) or with diﬀerent doses
of LPS (0.01, 0.1, 1 lg/ml), LTA (0.1, 1, and 10 lg/ml) and PG (0.1, 1,
and 10 lg/ml) for 24 h (b). Membranes of the stimulated A549 cells
were prepared as described in methods and the arginine-speciﬁc ART
activity assayed with the agmatine-standard assay. Data are
means ± S.D. of a representative experiment performed in triplicate.
Fig. 4. LTA and ﬂagellin increase ADP-ribosyltransferase activity and
ART1 expression in A549 cells. Membranes were obtained from cells
treated with LPS (0.1 lg/ml), LTA (1 lg/ml), PG (1 lg/ml), ﬂagellin
(10 lg/ml) or poly-IC (10 lg/ml) for 24 h and assayed for ADP-
ribosyltransferase activity using agmatine as ADP-ribose acceptor as
described in Section 2.3. Results are expressed as the means ± S.D.
(n = 3) (a). Immunoprecipitates (20 lg) from membranes used for
activity were electrophoresed and blotted, ART1 expression was
determined by immunoblotting with a-ART1 speciﬁc antibodies
diluted 1:1000. Data are representative of three independent experi-
ments, each of which exhibited similar results (b). Equal gel loading
was conﬁrmed by reprobing stripped membranes with a-actin antibody
diluted 1:5000 (c).
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As shown in Fig. 4b, both LTA and ﬂagellin signiﬁcantly up-
regulated ART1 expression, compared to un-stimulated con-
trol cells.
3.3. Diﬀerential regulation of ART1 and ART4 mRNA by
bacterial products
Since there are no enzymatic assays to detect the activity of
ART3 and ART4 that lack the R-S-EXE motif typical of argi-
nine-speciﬁc ARTs [17] and likely possess a diﬀerent amino-
acid speciﬁcity, we evaluated by RT-PCR the eﬀects of TLRs
agonists on ART gene expression. Culturing A549 for 24 h
with LPS, LTA, PG, ﬂagellin or poly(I:C) did not induce the
expression of either ART3 or ART5 mRNA, while a strong
stimulatory eﬀect on ART4 mRNA expression was found after
stimulation of cells with LPS, LTA and PG but not ﬂagellin
and poly(I:C) (Fig. 5a). The nucleotide sequencing identiﬁed
the ampliﬁed PCR product of 722 bp as ART4 mRNA. We
then repeated the stimulation with LPS, LTA, PG, adding also
the synthetic TLR2 agonist Pam3CSK4 (PAM). As shown in
Fig. 5b, the synthetic TLR2 agonist was as eﬀective as LTA
to induce ART4. A pretreatment of cells with anti-TLR4
and anti-TLR2 that functionally block TLR4 and TLR2 recep-
tors, respectively, before stimulation, inhibited ART4 activa-
tion indicating TLR4 and TLR2 involved in the mediation
of ART4 induction (Fig. 5b). The presence of anti-TLR2 did
not completely block the activation of the ART4 gene after
stimulation with PG. To validate more accurately the resultsobserved in Fig. 5a regarding the eﬀects of LTA and ﬂagellin
on ART1 we performed a qRT-PCR to measure ART1 speciﬁc
mRNA levels. A549 cells were stimulated as above described
including PAM. The results of the relative expression of
ART1 relative to the actin housekeeping signal are shown in
Fig. 5c. This proﬁle substantiates more clearly the proﬁle
shown in Fig. 5a, conﬁrming the up-regulation exerted on
ART1 gene by LTA but not by PAM, and ﬂagellin. The incu-
bation with TLR2 antagonist speciﬁcally blocks the ART1 up-
regulation by LTA indicating that the eﬀect is mediated by this
receptor.4. Discussion
Recent studies in human monocytes, have demonstrated that
PAMPs modulate ART expression [18], however, ART regula-
tion by bacterial products remained largely unexplored partic-
ularly in airway epithelial cells. Since we have previously
shown that ART1, ART3 and ART4 are expressed in interme-
diate and ciliated epithelial cells puriﬁed from bronchoalveolar
lavage (BAL) of healthy volunteers [4] we evaluated whether
PAMPs can modulate ARTs in A549 cells, a type II lung epi-
thelial cell line.
In this report, we provide evidence that A549 cells constitu-
tively express an enzimatically active ART1 on the cell surface.
Remarkably, ART1 was up-regulated both at mRNA and at
protein level by LTA and ﬂagellin but not by LPS, PAM,
PG, and poly(I:C). ART4 mRNA not constitutively expressed
by A549 was induced by LPS, LTA, PAM and PG but not by
ﬂagellin or poly(I:C).
Fig. 5. Eﬀect of diﬀerent TLR agonists on ART gene expression (a)
A549 cells were treated with LPS (0.1 lg/ml), LTA (1 lg/ml), PG (1 lg/
ml), ﬂagellin (10 lg/ml) or poly(I:C) (10 lg/ml) for 24 h. RNA was
extracted and ARTs mRNA levels assessed by RT-PCR ampliﬁcation
as described in Section 2. Control RT-PCR was carried out with
human skeletal muscle (ART1), human testis (ART3), human spleen
(ART4) and human testis (ART5) RNA. Molecular mass markers (M)
were used to conﬁrm the size of the PCR products. The results
presented in this panel were conﬁrmed in two independent experiments
using diﬀerent A549 preparations (a). (b) A549 cells were treated as
above described including PAM (1 lg/ml). In other experiments cells
were pre-incubated with 20 lg/ml of anti-TLR4 (HTA125) or 50 lg/ml
of anti-TLR2 (T2.5) for 1 h at 37 C before adding PAMPs as above
described. Total RNA was puriﬁed after 24 h of incubation and
processed as before to assess the levels of ART4 mRNA. (c) Real-time
quantitative RT-PCR analysis of ART1 transcript in A549 after
stimulation of cells with PAMPs using the same conditions as
described in (a). Data shown are relative expression of ART1 mRNA
with respect to the actin housekeeping signal. Data are means ± S.D.
of a representative experiment performed in triplicate.
E. Balducci et al. / FEBS Letters 581 (2007) 4199–4204 4203The ART family is a group of proteins structurally related to
ADP-ribosylating toxins. ART1 and ART5 that transfer the
ADP-ribose moiety to arginine are likely candidates for the
ART activity found in these cells. Identiﬁcation of ART1 tran-
scripts and speciﬁc silencing indicated ART1 responsible for
the activity. Immunostaining with a-ART1 polyclonal anti-
bodies conﬁrmed the presence of the protein associated tothe cell membrane and localization experiments performed
with intact cells, showed that the catalytic site of this enzyme
is located on the outer side of the cell membrane, the same ori-
entation found for ART1 on polarized and intermediate epi-
thelial cells puriﬁed from bronchoalveolar lavage [4].
A549 produce b-defensins in response to LTA [13] and this
eﬀect is sustained over the 24 h time period [19]. Defensins ex-
hibit a wide range of antimicrobial activities but are also cyto-
toxic for several types of mammalian cells including A549 [20].
Interestingly, a-defensins are substrate of ART1 in bronchoal-
veolar lavage ﬂuids of habitual smokers and it has been shown
that while ADP-ribosylated-defensins retained their chemoat-
tractant activity they lost cytotoxic activity [5]. Defensins reach
cytotoxic concentrations during lung inﬂammation determin-
ing severe damage to epithelial cells [21]. Enhancement of
ART1 activity and expression could cause an increase in
ADP-ribosylated defensins and this might protect cells lining
the airway lumen from negative eﬀects of cytotoxic concentra-
tions of antimicrobial peptides. As lung epithelia is particularly
exposed to inﬂammation this observation might be of clinical
relevance.
While we failed to induce expression of ART3 and ART5
mRNA with the TLR agonists used, our results show that
LTA, LPS, PAM and PG exerted a strong activation of
ART4 gene expression. Inhibition exerted by functional anti-
bodies to TLR2 and TLR4 indicates that this eﬀect is mediated
by TLR2 and TLR4 receptors. These results conﬁrm that, as
others reported in monocytes, ART4 regulation at least at
mRNA level, is a more general intracellular event related to
cell-activation by a variety of extracellular stimuli [18]. The im-
mune response to bacterial ﬂagellin is mediated by TLR5 [22]
and likely this receptor mediates the ART1 up-regulation. On
the contrary while PAM the synthetic TLR2 ligand does not
up-regulate ART1 transcript, TLR2 is involved in LTA regu-
lation. This discrepancy as above for PG activation of ART4
could be explained by the presence of contaminants in puriﬁed
PAMPs and not in synthetic agonists, which can activate dif-
ferent TLRs [14]. Overall the above observations lead to a dif-
ferential response of the ARTs to the TLR agonists. These
eﬀects may be only partially explained by the heterogeneity
in expression of TLR4 and TLR2 in these cells. TLR4 is not
surface expressed in A549 [12], but the intracellular receptor
is functionally responsive to LPS [12] and in A549 mediates
ART4 activation as our results evidence. It has been shown re-
cently that non-hematopoietic cells including epithelial cells
play a crucial role for NOD-1 innate immune recognition of
PG [23]. Given their large surface area, lung epithelial cells
interacting with pathogens might play a primary role in inﬂam-
matory response recruiting immunological cells, therefore our
studies highlighting the stimulatory eﬀect elicited by TLR ago-
nists speciﬁcally mediated by TLR2, TLR4 and TLR5 recep-
tors on ARTs are relevant to support the involvement of
mono ADP-ribosylation in immune response in airways.
Although ARTs are structurally and functionally related pro-
teins, they might follow diﬀerent pathway of activation in re-
sponse to PAMPs, suggesting diﬀerent physiological roles
and indicating that the challenge of future studies will be
exploring the speciﬁc role of ART1 and ART4 in inﬂamma-
tory disorders.
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